<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Harvard Law School Forum on Corporate Governance</title>
	<atom:link href="https://corpgov.law.harvard.edu/2026/07/18/comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5/feed/" rel="self" type="application/rss+xml" />
	<link>https://corpgov.law.harvard.edu</link>
	<description>The leading online blog in the fields of corporate governance and financial regulation.</description>
	<lastBuildDate>Sat, 18 Jul 2026 11:30:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.8</generator>

<image>
	<url>https://corpgov.law.harvard.edu/wp-content/uploads/2024/02/cropped-photography-4-e1706898544564-1-32x32.png</url>
	<title>Comment Letter on the SEC&#8217;s Proposal to Replace Quarterly Reporting with Semiannual Reporting &#8211; The Harvard Law School Forum on Corporate Governance</title>
	<link>https://corpgov.law.harvard.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Comment Letter on the SEC&#8217;s Proposal to Replace Quarterly Reporting with Semiannual Reporting</title>
		<link>https://corpgov.law.harvard.edu/2026/07/18/comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5</link>
		<comments>https://corpgov.law.harvard.edu/2026/07/18/comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5/#respond</comments>
		<pubDate>Sat, 18 Jul 2026 11:30:01 +0000</pubDate>
<!-- 		<dc:creator><![CDATA[]]></dc:creator> -->
				<category><![CDATA[Practitioner Publications]]></category>
		<category><![CDATA[SEC Comment letters]]></category>
		<category><![CDATA[Comment letters]]></category>
		<category><![CDATA[File No. S7-2026-15]]></category>
		<category><![CDATA[Financial reporting]]></category>
		<category><![CDATA[Form 10-Q]]></category>
		<category><![CDATA[Form 10-S]]></category>
		<category><![CDATA[Periodic reporting]]></category>
		<category><![CDATA[Public Company Disclosure]]></category>
		<category><![CDATA[Quarterly Reporting]]></category>
		<category><![CDATA[SEC]]></category>
		<category><![CDATA[SEC rulemaking]]></category>
		<category><![CDATA[Semiannual Reporting]]></category>

		<guid isPermaLink="false">https://corpgov.law.harvard.edu/?p=182647?d=20260717155629EDT</guid>
		<description><![CDATA[The pharmaceutical companies listed below (the “Companies”) jointly submit this letter in support of the Securities and Exchange Commission’s (the “Commission”) proposed semiannual reporting rule. As public companies, including several with longstanding reporting practices, the Companies are well-positioned to offer perspective on how this proposal would function in practice. Companies: Bristol Myers Squibb Company Eli [&#8230;]]]></description>
				<content:encoded><![CDATA[<hgroup><em>Posted by Donald A. Zakrowski, Eli Lilly and Co., on Saturday, July 18, 2026 </em><div class='e_n' style='background:#F8F8F8;padding:10px;margin-top:5px;margin-bottom:10px;text-indent:2.5em;'><strong style='margin-left:-2.5em;'>Editor's Note: </strong> <p style="margin:0; display:inline;"><span style="font-size: 13.3333px;">Donald A. Zakrowski is Senior Vice President, Finance, and Chief Accounting Officer at Eli Lilly &amp; Co. This post is based on his SEC comment letter.</span></p>
</div></hgroup><p>The pharmaceutical companies listed below (the “Companies”) jointly submit this letter in support of the Securities and Exchange Commission’s (the “Commission”) proposed semiannual reporting rule. As public companies, including several with longstanding reporting practices, the Companies are well-positioned to offer perspective on how this proposal would function in practice.</p>
<p><em>Companies:</em></p>
<ul>
<li>Bristol Myers Squibb Company</li>
<li>Eli Lilly and Company</li>
<li>Gilead Sciences, Inc.</li>
<li>Johnson &amp; Johnson</li>
<li>Merck &amp; Co., Inc.</li>
<li>Pfizer Inc.</li>
<li>Roivant Sciences Ltd.</li>
<li>Viatris Inc.</li>
<li>Zoetis Inc</li>
</ul>
<p> <a href="https://corpgov.law.harvard.edu/2026/07/18/comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5/#more-182647" class="more-link"><span aria-label="Continue reading Comment Letter on the SEC&#8217;s Proposal to Replace Quarterly Reporting with Semiannual Reporting">(more&hellip;)</span></a></p>
]]></content:encoded>
			<wfw:commentRss>https://corpgov.law.harvard.edu/2026/07/18/comment-letter-on-the-secs-proposal-to-replace-quarterly-reporting-with-semiannual-reporting-5/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
